Sun Guoqiang

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Sun Guangshun, Sun Guoqiang, Chen Xin, Kong Xiangyi, Zheng Wubin, Li Zhitao, Zheng Zhiying, Hongyong Cao, Lv Chengyu, Yongxiang Xia, Weiwei Tang
Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway. Journal of oncology 2022 (2022)